In a recent Eye Contact interview, Dr Richard Packard was asked if he saw robotics coming into the area of cataract surgery. He doesn’t see it happening any time soon.
Balkan and Serbian Ophthalmology was created and influenced by many important and interesting contributors. Here we profile Professor Dorde Nešić who was the founder of ophthalmology in Serbia.
The availability of anti-VEGF agents, such as intravitreal ranibizumab (Lucentis, Genentech), has revolutionised the management of various forms of ocular neovascularisation, including myopic CNV (mCNV)
Polypoidal choroidal vasculopathy (PCV) is a complex disease and may require a customised approach that draws on different treatment strategies to ensure the best patient outcomes in the long term
Most SMILE complications are mild and diminish in frequency
with experience. Roibeard Ó hÉineacháin reports
Preparation of lenticule backside: Oval shape of opaque bubble layer for correction of high astigmatism. Courtesy of Suphi Taneri MD Small-incision lenticule extraction (SMILE) appears to be safe and effective for astigmatism correction, although cyclotorsion could be an issue, according to two early studies presented at the XXXV Congress of the ESCRS in Lisbon, Portugal. […]
Technological innovation is crucial to the continued improvement of vitreoretinal surgery. The RetinaTech Bio-Engineering Session during the 17th EURETINA Congress in Barcelona, Spain subtitled “Where Surgery Meets Technology”, featured a group of 12 highly experienced vitreoretinal surgeons
Paul Rosen interviews Patrick Condon about the early days of phacoemulsification. Irish surgeon Patrick Condon visited Charles Kelman in New York, where he observed surgeries and travelled with Kelman by private helicopter, as well as later bringing him to Ireland in the mid-1980s. He also worked with Eric Arnott in London, where he learned the […]
Sean Henahan talks to Sathish Srinivasan about the pupillary and visual axis debate and the current consensus among ophthalmologists regarding the correct terminology to be used.
Béatrice Cochener talks to Walter Sekundo about some of the first results with SMILE in the treatment of hyperopia and astigmatism.
Toric IOLs have proven to be an excellent solution for higher levels of astigmatism. However, there are challenges in calculating the IOL power, challenges with the actual surgery. Dr Rudy Nuijts, of the University Eye Clinic Maastricht, the Netherlands, and Dr Nino Hirnschall, a researcher at the Vienna Institute for Research in Ocular Surgery, bring […]
Sean Henahan talks to Dr Jenny Yu, Vice Chair of Clinical Operations for the Department of Ophthalmology, University of Pittsburgh Eye Center about complications when dealing with the orbit, facial structures, and the skull base.
A fascinating area of research involves the development of innovative eye drop systems that could someday replace intravitreal injections. Jesper Hjortdal talks to a pioneer in the field, Dr Einar Stefánsson, about new approaches to ocular drug delivery.
Corneal neovascularisation is a serious condition that can lead to a profound decline in vision. How can this problem best be managed? Sean Henahan talks to Claus Cursiefen.
Some 50 years after Fyodorov published the first paper on theoretical IOL power calculation, achieving an ideal patient outcome still remains a challenge. Dr Jaime Aramberri talks to Dr Warren Hill, Mesa, Arizona, US about an innovative approach using artificial intelligence, the “Hill-radial basis function”.
Béatrice Cochener interviews François Malecaze, who delivered the EuCornea Medal lecture at the 8th EuCornea Congress in Lisbon, Portugal.
Penetrating keratoplasty was the original, and for a long time, the most common keratoplasty procedure. Professor Dan Epstein discusses the longer term results of keratoplasty with Professor Beatrice Frueh.
Sean Henahan talks to Bekir Sitki Aslan, Head of Eye Department, Ankara Memorial Hospital, Turkey about what has changed 50 years after the introduction of phaco.
It is challenging to identify patients with the early stages of the disease. But overenthusiastic screening could lead to other people receiving treatment who really don’t need it. Dr Ingeborg Stalmans talks with Dr Fotis Topouzis about glaucoma underdiagnosis and overdiagnosis.